Black Bird Biotech, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Nelson Grist
- Full Time Employees
- 4
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 3505 Yucca Drive Argyle TX United States of America 75028
- IPO Date
- Nov 11, 2009
- CIK
- 0001409999
- Website
- blackbirdpotentials.com
- Similar Companies
- Business
- Black Bird Biotech, Inc. (OTC: BBBT) is a specialty biotechnology company that manufactures and distributes plant-based agricultural and wellness products, including its flagship EPA-registered biopesticide MiteXstream, a 100% plant-based solution that eradicates spider mites, other pests, molds, and mildews on crops such as cannabis, grapes, hops, coffee, and strawberries, usable through harvest day without residual concerns; Grizzly Creek Naturals cannabidiol (CBD) oils, gummies, pet treats, and personal care products; and Black Bird American Hemp industrial hemp products, including nutrient-dense hemp hearts under the Montana Hemp pilot program. The company, founded in 2006 and headquartered in Argyle, Texas, operates primarily in the United States through its subsidiary Black Bird Potentials, Inc., targeting agricultural growers, cannabis cultivators, and wellness consumers in the pharmaceuticals and biotech sectors. Formerly known as Digital Development Partners, Inc., Black Bird Biotech changed its name in June 2021 to reflect its focus on biotech innovations; it completed a Regulation A funding round in late 2021, using proceeds to repay approximately $700,000 in convertible debt and invest in sales, marketing, and inventory for MiteXstream, while pursuing uplisting to the OTCQB Venture Market.
Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path
Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users
Black Bird Biotech Retires Three Separate Convertible Notes with Cash Repayments
Black Bird Biotech Announces Important Wide-Ranging Field Tests of its Disruptive MiteXstreamTM Biopesticide by A Second International Agri-Chemical Distributor Based in the Middle East
Black Bird Biotech Seeks Approval in All Remaining States, to Open Up Entire US Market, Including the Projected $45 Billion Cannabis Industry, for its Disruptive Plant-Based MiteXstreamTM Biopesticide Sales Efforts
Black Bird Biotech Announces First Sales of Disruptive Plant-Based MiteXstreamTM Biopesticide, Prepares for Fourth Quarter Marketing Push Within Cannabis Industry
Black Bird Biotech to Seek EPA Approval of MiteXstream(TM) Ready-to-Use Formulation
Black Bird Biotech Announces MiteXstream Summer Field Testing on Mite-Plagued Vegetable Crops in Israel by International Agri-Chem Company